Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
Gazyva (obinutuzumab) - Roche, Biogen, Nippon Shinyaku
Lupus Nephritis in Children: Novel Perspectives. (PubMed, Medicina (Kaunas)) - Oct 28, 2023 - "Moreover, current literature often lacks pediatric-specific data, leading clinicians to rely exclusively on adult therapeutic approaches. This review aims to describe pediatric lupus nephritis and provide an overview of the novel perspectives on the pathogenetic mechanisms, histopathological classification, therapeutic approach, novel biomarkers, and follow-up targets in children and adolescents with lupus nephritis." 
Journal • Review • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics • Systemic Lupus Erythematosus
http://www.ncbi.nlm.nih.gov/pubmed/37893559
 
Marco Pennesi; Simone Benvenuto
 
Oct 28, 2023
 
Prev Next